Difficulty: Medium
Average Score: 82%
Practice
Alpha-glucosidase inhibitors act by:
Correct answer
B
Rationale
The correct answer is B) Competitive inhibiting of intestinal alpha-glucosidases and modulating the postprandial digestion and absorption of starch and disaccharides.
Alpha-glucosidase inhibitors, such as acarbose and miglitol, work by inhibiting the enzymes in the small intestine responsible for breaking down complex carbohydrates into simple sugars. By slowing the digestion and absorption of carbohydrates, these drugs help in reducing the postprandial rise in blood glucose levels. This mechanism of action is crucial in managing conditions like diabetes mellitus by preventing rapid spikes in blood sugar after meals.
Option A is incorrect because alpha-glucosidase inhibitors do not directly affect insulin resistance or glucose uptake in muscle and adipose tissues. Option C is also incorrect as these drugs do not reduce the absorption of carbohydrates from the gut but rather slow down the process. Option D is misleading as alpha-glucosidase inhibitors do not stimulate pancreatic beta cells to produce insulin; instead, they act locally in the intestine to modulate carbohydrate digestion.
Understanding the mechanism of action of different classes of drugs is essential for healthcare professionals, especially pharmacists and nurses, involved in managing patients with cardiovascular diseases and diabetes. By grasping how alpha-glucosidase inhibitors work, healthcare providers can make informed decisions when selecting appropriate treatment options for their patients based on the underlying pathophysiology of the condition.
Alpha-glucosidase inhibitors, such as acarbose and miglitol, work by inhibiting the enzymes in the small intestine responsible for breaking down complex carbohydrates into simple sugars. By slowing the digestion and absorption of carbohydrates, these drugs help in reducing the postprandial rise in blood glucose levels. This mechanism of action is crucial in managing conditions like diabetes mellitus by preventing rapid spikes in blood sugar after meals.
Option A is incorrect because alpha-glucosidase inhibitors do not directly affect insulin resistance or glucose uptake in muscle and adipose tissues. Option C is also incorrect as these drugs do not reduce the absorption of carbohydrates from the gut but rather slow down the process. Option D is misleading as alpha-glucosidase inhibitors do not stimulate pancreatic beta cells to produce insulin; instead, they act locally in the intestine to modulate carbohydrate digestion.
Understanding the mechanism of action of different classes of drugs is essential for healthcare professionals, especially pharmacists and nurses, involved in managing patients with cardiovascular diseases and diabetes. By grasping how alpha-glucosidase inhibitors work, healthcare providers can make informed decisions when selecting appropriate treatment options for their patients based on the underlying pathophysiology of the condition.